DD210060A5 - Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten - Google Patents

Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten Download PDF

Info

Publication number
DD210060A5
DD210060A5 DD83253192A DD25319283A DD210060A5 DD 210060 A5 DD210060 A5 DD 210060A5 DD 83253192 A DD83253192 A DD 83253192A DD 25319283 A DD25319283 A DD 25319283A DD 210060 A5 DD210060 A5 DD 210060A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
optionally substituted
omt
deep
Prior art date
Application number
DD83253192A
Other languages
German (de)
English (en)
Inventor
Herbert A Kirst
John E Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD210060A5 publication Critical patent/DD210060A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD83253192A 1982-07-19 1983-07-19 Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten DD210060A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/399,657 US4459290A (en) 1982-07-19 1982-07-19 C-23-Modified derivatives of OMT, pharmaceutical compositions and method of use

Publications (1)

Publication Number Publication Date
DD210060A5 true DD210060A5 (de) 1984-05-30

Family

ID=23580431

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83253192A DD210060A5 (de) 1982-07-19 1983-07-19 Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten

Country Status (19)

Country Link
US (1) US4459290A (fr)
EP (1) EP0099747B1 (fr)
JP (1) JPS5931795A (fr)
KR (1) KR850000967B1 (fr)
AT (1) ATE25689T1 (fr)
AU (1) AU1693483A (fr)
CA (1) CA1202965A (fr)
DD (1) DD210060A5 (fr)
DE (1) DE3369997D1 (fr)
DK (1) DK330383D0 (fr)
ES (1) ES8504840A1 (fr)
FI (1) FI832603A (fr)
GB (1) GB2123828B (fr)
GR (1) GR78388B (fr)
NZ (1) NZ204939A (fr)
PH (1) PH19929A (fr)
PL (1) PL243090A1 (fr)
PT (1) PT77039A (fr)
ZA (1) ZA835217B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515941A (en) * 1982-04-07 1985-05-07 Toyo Jozo Kabushiki Kaisha 23-Demycinosyldesmycosin derivatives
JPS59141596A (ja) * 1983-02-03 1984-08-14 Toyo Jozo Co Ltd ３−ｏ−アシル−４″−デオキシデスマイコシン誘導体およびその製法
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
DE3310533A1 (de) * 1983-03-23 1984-09-27 Bayer Ag, 5090 Leverkusen Organisch-chemische verbindungen und verfahren zu ihrer herstellung
JPS6098540A (ja) * 1983-11-04 1985-06-01 Mitsubishi Electric Corp 磁気記録再生装置
JPS60115038A (ja) * 1983-11-26 1985-06-21 Mitsubishi Electric Corp 磁気録画再生装置
US4604380A (en) * 1985-01-18 1986-08-05 Eli Lilly And Company C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
US4581345A (en) * 1985-04-08 1986-04-08 Merck & Co., Inc. Avermectin 8,9-cyclopropyl compounds, pharmaceutical composition and therapeutic methods of use
US6753415B2 (en) 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives
EP1849796B1 (fr) 2005-01-24 2014-11-05 Microbial Chemistry Research Foundation Agent anti-pneumococci résistantes à la pénicilline et nouveau dérivé de macrolide cyclique à 16 chaînons

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667952A (fr) * 1964-08-05
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
JPS56122397A (en) * 1980-02-29 1981-09-25 Satoshi Omura Marcolides
US4321362A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company De(mycinosyloxy)tylosin and process for its production
US4438109A (en) * 1980-07-25 1984-03-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Tylosin derivatives
US4341770A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling ureaplasma infections
US4341771A (en) * 1981-04-20 1982-07-27 Eli Lilly And Company Method of controlling Pasteurella infections
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives

Also Published As

Publication number Publication date
ES524196A0 (es) 1985-05-01
ES8504840A1 (es) 1985-05-01
JPS5931795A (ja) 1984-02-20
DE3369997D1 (en) 1987-04-09
EP0099747B1 (fr) 1987-03-04
ZA835217B (en) 1984-03-28
KR840005463A (ko) 1984-11-12
PH19929A (en) 1986-08-14
CA1202965A (fr) 1986-04-08
GB2123828A (en) 1984-02-08
DK330383D0 (da) 1983-07-18
GR78388B (fr) 1984-09-26
NZ204939A (en) 1986-08-08
AU1693483A (en) 1984-01-26
GB8319307D0 (en) 1983-08-17
PL243090A1 (en) 1984-07-16
PT77039A (en) 1983-08-01
ATE25689T1 (de) 1987-03-15
FI832603A (fi) 1984-01-20
US4459290A (en) 1984-07-10
GB2123828B (en) 1985-11-13
FI832603A0 (fi) 1983-07-18
EP0099747A1 (fr) 1984-02-01
KR850000967B1 (ko) 1985-07-02

Similar Documents

Publication Publication Date Title
DE69733422T2 (de) 6-0-substituierte ketoliden mit antibakteriellen wirkung
DE69832486T2 (de) C-4"-substitutierte macrolid-derivate
DE69114198T2 (de) O-Methylderivate von Azithromycin A, Verfahren und Zwischenverbindungen zu ihrer Herstellung und deren Verwendung zur Herstellung von Heilmitteln.
US4512982A (en) 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
DE60220180T2 (de) 14 bis 15 gliedrige makrolide mit antibakterieller aktivität
DE60123277T2 (de) Makrolidantibiotika
DE69315839T2 (de) Derivate von 16-gliedrigen antibiotischen macroliden
DE69824201T2 (de) Neue 9a-azalide
KR850000961B1 (ko) 20-아미노 마크로라이드 유도체의 제조방법
US5215980A (en) 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
DD210060A5 (de) Verfahren zur herstellung von 5-0-mycaminosyltylonolidderivaten
DE69402714T2 (de) Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
DE2804508C2 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung als antibakterielle Wirkstoffe
DD210283A5 (de) Verfahren zur herstellung von 20-aminotylosin-derivaten
DD211565A5 (de) Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel
DE69022845T2 (de) Erythromycinderivate.
DE3100739A1 (de) Pseudotrisaccharide, verfahren zu deren herstellung, deren verwendung als arzneimittel und die pseudotrisaccharide enthaltende arzneimittel sowie deren herstellung
HU211975A9 (en) Derivatives of tylosin and 10,11,12,13-tetrahydrotylosin and their use in pharmaceuticals
DE2804517C3 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung bei der Bekämpfung von Bakterien
DE3878835T2 (de) Antibakterielle 9-deoxy-9a-allyl und propargyl-9a-aza-9a-homoerythromycin-a-derivate.
DE69217398T2 (de) Verfahren zur Herstellung von 9-deoxo-9(z)-hydroxyiminoerythromycin A
EP0022504B1 (fr) Dérivés de 1-N-alkylsisomicine, procédé pour leur préparation et leur application comme produits pharmaceutiques
DE3788389T2 (de) Cervinomycinabkömmlinge als antibiotika und deren herstellungsverfahren.
DE2804507C2 (de) 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel
DD210059A5 (de) Verfahren zur herstellung von in stellung c-23 modifizierten derivaten von dmt